Literature DB >> 7811747

Sequential changes in glycolipid expression during human B cell differentiation: enzymatic bases.

S Taga1, C Tétaud, M Mangeney, T Tursz, J Wiels.   

Abstract

We have previously reported that human B cell differentiation is accompanied by sequential changes in glycosphingolipid expression. Pre-B cells contain lacto-series type II chain-based glycolipids and GM3 ganglioside; mature/activated B cells do not synthesize lacto-series compounds but express GM3 and globo-series glycolipids (Gb3 and Gb4); terminally differentiated B cells, in addition to these compounds, also contain GM2 ganglioside. At the cell surface, Gb3, Gb4 and GM2 constitute stage-specific antigens. To elucidate the biosynthetic mechanism leading to these modifications we have compared activities of the glycosyltransferases involved in the core structure assembly and the first elongation steps of neo-lacto, ganglio- and globo-series glycolipids. These glycosyltransferase activities have been measured in B cell lines and normal B lymphocytes at various stages of differentiation. We first determined the optimal requirements of the four glycosyltransferases which synthesize Lc3, GM3, Gb4 and GM2 glycolipids in B lymphocytes and then tested these enzymes and the Gb3 synthetase in the selected B cells. The following results were obtained: beta 1-->3 N-Acetylglucosaminyltransferase (Lc3 synthetase) has a high activity in pro- and pre-B cells whereas it is undetectable in more differentiated cells; alpha 2-->3 sialytransferase (GM3 synthetase) is activated from the pre-B cell stage to the terminally differentiated myeloma cells; alpha 1-->4 galactosyltransferase (Gb3 synthetase) is only detected in cells representing the late stages of B cell differentiation; beta 1-->3 N-Acetylgalactosaminyltransferase (Gb4 synthetase) is only found in some lymphoblastoid cell lines, representative of activated B cells whereas the beta 1-->4 N-Acetylgalactosaminyltransferase (GM2 synthetase) has a high activity in these lymphoblastoid cell lines and in terminally differentiated myeloma cells. These results suggest that the sequential shifts in the three major glycosphingolipid series observed during B cell differentiation are mostly due to sequential activations of the corresponding glycosyltransferases.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7811747     DOI: 10.1016/0005-2760(94)00167-w

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  8 in total

1.  Histo-blood group p: biosynthesis of globoseries glycolipids in EBV-transformed B cell lines.

Authors:  J Wiels; S Taga; C Tétaud; B Cedergren; B Nilsson; H Clausen
Journal:  Glycoconj J       Date:  1996-08       Impact factor: 2.916

2.  Activation state and intracellular trafficking contribute to the repertoire of endogenous glycosphingolipids presented by CD1d [corrected].

Authors:  Karen Muindi; Manuela Cernadas; Gerald F M Watts; Louise Royle; David C A Neville; Raymond A Dwek; Gurdyal S Besra; Pauline M Rudd; Terry D Butters; Michael B Brenner
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-28       Impact factor: 11.205

3.  Alpha 1,4galactosyltransferase activity and Gb3Cer expression in human leukaemia/lymphoma cell lines.

Authors:  C L Stults; R D Larsen; B A Macher
Journal:  Glycoconj J       Date:  1995-10       Impact factor: 2.916

Review 4.  Elucidation of the enigma of glycosphingolipids in the regulation of inflammation and degeneration - Great progress over the last 70 years.

Authors:  Koichi Furukawa; Yuhsuke Ohmi; Yuji Kondo; Robiul H Bhuiyan; Orie Tajima; Pu Zhang; Yuki Ohkawa; Keiko Furukawa
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2019       Impact factor: 3.493

Review 5.  The Role of Glycosphingolipids in Immune Cell Functions.

Authors:  Tao Zhang; Antonius A de Waard; Manfred Wuhrer; Robbert M Spaapen
Journal:  Front Immunol       Date:  2019-01-29       Impact factor: 7.561

Review 6.  Molecular Biology of Escherichia Coli Shiga Toxins' Effects on Mammalian Cells.

Authors:  Christian Menge
Journal:  Toxins (Basel)       Date:  2020-05-23       Impact factor: 4.546

Review 7.  Valid Presumption of Shiga Toxin-Mediated Damage of Developing Erythrocytes in EHEC-Associated Hemolytic Uremic Syndrome.

Authors:  Johanna Detzner; Gottfried Pohlentz; Johannes Müthing
Journal:  Toxins (Basel)       Date:  2020-06-04       Impact factor: 4.546

Review 8.  The Role of Escherichia coli Shiga Toxins in STEC Colonization of Cattle.

Authors:  Christian Menge
Journal:  Toxins (Basel)       Date:  2020-09-21       Impact factor: 4.546

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.